Literature DB >> 10478414

The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive.

C Bates1, A McNeill, M Jarvis, N Gray.   

Abstract

The European Commission has announced that it is considering legislation concerning further restrictions on cigarette tar and nicotine yields, as well as new provisions to regulate additives and the labelling of tobacco products. This report considers these issues and their relation to public health. In particular, we argue that further reductions in tar and nicotine yields as measured by the International Standards Organisation/Federal Trade Commission (ISO/FTC) method will be largely cosmetic and certainly misleading to consumers. If a new directive uses the ISO/FTC methodology as a basis for regulation, it risks lending further official support to the concept of "low tar" cigarettes, which may be used by smokers as an alternative to smoking cessation. Although new regulations based on the ISO/FTC methodology may appear to offer health gains, these will be illusory and there may even be negative health consequences, as has been the case with these tests up to the present. We therefore make the following recommendations for the way forward.

Entities:  

Mesh:

Year:  1999        PMID: 10478414      PMCID: PMC1759708          DOI: 10.1136/tc.8.2.225

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  10 in total

1.  Eliminating nicotine in cigarettes.

Authors:  M J Jarvis; C Bates
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II. Results of a randomised controlled trial.

Authors:  C H Withey; A O Papacosta; A V Swan; B A Fitzsimons; G A Ellard; P G Burney; J R Colley; W W Holland
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

3.  Tar concentrations in cigarettes and carcinogen content.

Authors:  N Gray; P Boyle; W Zatonski
Journal:  Lancet       Date:  1998-09-05       Impact factor: 79.321

4.  Low-tar medium-nicotine cigarettes: a new approach to safer smoking.

Authors:  M A Russell
Journal:  Br Med J       Date:  1976-06-12

5.  The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.

Authors:  C Frost; F M Fullerton; A M Stephen; R Stone; A Nicolaides-Bouman; J Densem; N J Wald; A Semmence
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

6.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

Review 7.  The changing cigarette.

Authors:  D Hoffmann; M V Djordjevic; I Hoffmann
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

8.  Impact of filter cigarette smoking on lung cancer histology.

Authors:  S D Stellman; J E Muscat; D Hoffmann; E L Wynder
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

Review 9.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

10.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

  10 in total
  17 in total

1.  Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?

Authors:  J E Henningfield; K O Fagerstrom
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

Review 2.  Regulatory strategies to reduce tobacco addiction in youth.

Authors:  J E Henningfield; E T Moolchan; M Zeller
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

Review 3.  Dependence of tar, nicotine and carbon monoxide yields on physical parameters: implications for exposure, emissions control and monitoring.

Authors:  W E Stephens
Journal:  Tob Control       Date:  2007-06       Impact factor: 7.552

4.  Trends in sales weighted tar, nicotine, and carbon monoxide yields of UK cigarettes.

Authors:  M J Jarvis
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 5.  Toward a comprehensive long term nicotine policy.

Authors:  N Gray; J E Henningfield; N L Benowitz; G N Connolly; C Dresler; K Fagerstrom; M J Jarvis; P Boyle
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

Review 6.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

Review 7.  "If we can just 'stall' new unfriendly legislations, the scoreboard is already in our favour": transnational tobacco companies and ingredients disclosure in Thailand.

Authors:  R MacKenzie; J Collin; K Sriwongcharoen; M E Muggli
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

8.  Whose standard is it, anyway? How the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco and tobacco products.

Authors:  S A Bialous; D Yach
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

9.  Self-administration of nicotine and cigarette smoke extract in adolescent and adult rats.

Authors:  Candice A Gellner; James D Belluzzi; Frances M Leslie
Journal:  Neuropharmacology       Date:  2016-06-23       Impact factor: 5.250

10.  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Authors:  Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.